机译:在急诊科胸痛人群中使用新一代高灵敏度研究性心肌钙蛋白I(hs-cTnI)测定的短期和长期风险分层
Peter A. Kavsak,1* Xuesong Wang,2 Dennis T. Ko,2 Andrew R. MacRae,3 and Allan S. Jaffe41 Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada, 2 Institute for Clinical Evaluative Sciences, University of Toronto, ON, Canada, 3 Department of Biochemistry and Medical Genetics, University of Manitoba, Winnipeg, MB, Canada, and 4 Cardiovascular Division and Division of Laboratory Medicine, Mayo Clinic, Rochester, MN.* Address correspondence to this author at: Hamilton Regional Laboratory Medicine Program, Henderson General Hospital (Core Lab Section), 711 Concession St., Hamilton, ON, Canada. Fax 905-575-2581, e-mail kavsakp@mcmaster.ca.Received March 12, 2009, accepted July 15, 2009.Previously published online at DOI: 10.1373/clinchem.2009.127241Author Contributions: All authors confirmed they have contributed to the intellectual content of this paper and have met the following 3 requirements: (a) significant contributions to the conception and design, acquisition of data, or analysis and interpretation of data, (b) drafting or revising the article for intellectual content, and (c) final approval of the published article.Authors' Disclosures of Potential Conflicts of Interest: Upon manuscript submission, all authors completed the Disclosures of Potential Conflict of Interest form. Potential conflicts of interest:Employment or Leadership: None declared.Consultant or Advisory Role: A.R. MacRae, Beckman Coulter, A.S. Jaffe, Siemens, Beckman Coulter, Ortho Diagnostics, Singulex, Nanosphere, Inverness, Critical Diagnostics, GlaxoSmithKline, and Novartis.Stock Ownership: None declared.Honoraria: P.A. Kavsak, Beckman Coulter.Research Funding: Canadian Institutes of Health Research. P.A. Kavsak, Beckman Coulter. A.S. Jaffe, Siemens and Beckman Coulter. Reagents were provided as an unrestricted grant by Beckman Coulter.Expert Testimony: None declared.Role of Sponsor: The funding organizations played no role in the design of study, choice of enrolled patients, review and interpretation of data, or preparation or approval of manuscript.Acknowledgments: Special thanks to the Clinical Research and Clinical Trials Laboratory, Hamilton, for performing the laboratory measurements.,;
机译:在急诊科胸痛人群中,使用下一代高敏感性研究性心肌肌钙蛋白I(hs-cTnI)分析进行短期和长期风险分层。
机译:在急诊科胸痛人群中使用下一代高敏感性研究性心肌钙蛋白I(hs-cTnI)测定的短期和长期风险分层
机译:胸痛患者的临床结果从急诊部门使用高灵敏度与常规心肌肌钙蛋白测定的急诊部门
机译:智能纺织品在急诊科胸痛患者中的应用
机译:非心脏性胸痛人群中的心理和社会人口统计学因素会影响心脏压力测试的表现。
机译:短期和长期风险分层使用新一代高灵敏度研究心肌肌钙蛋白I(Hs-cTnI)水平检测在急诊胸痛人口
机译:使用下一代高敏感性研究心肌肌钙蛋白I(HS-CTNI)测定的短期和长期风险分层在急诊部胸痛人口中